Clinical data | |
---|---|
Trade names | Rudotel |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 50–75% (Сmax = 1–2 hours) |
Protein binding | >99% |
Metabolism | Hepatic |
Elimination half-life | 2 hours, 36–150 hours (terminal) |
Excretion | Renal (63–85%), Biliary 15–37% |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.018.895 |
Chemical and physical data | |
Formula | C16H15ClN2 |
Molar mass | 270.76 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Medazepam is a drug that is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It is known by the following brand names: Azepamid, Nobrium, Tranquirax (mixed with bevonium), Rudotel, Raporan, Ansilan and Mezapam.[2] Medazepam is a long-acting benzodiazepine drug. The half-life of medazepam is 36–200 hours.[3]